The mean baseline body weight was 89.9 kg, 89.2 kg, 89.3 kg in the OZEMPIC 0.5 mg, OZEMPIC 1 mg, and sitagliptin arms, respectively
The fact that we found that there is potentially an increased risk in with gastroparesis (stomach paralysis) in people who use these drugs for weight loss, that was quite surprising for us just to kind of lend support to what some of these people have been experiencing. To figure out whether there was a link between these weight loss drugs and issues like stomach paralysis, the researchers looked at health insurance claim records of around 16 million patients in the United States
Chronic pancreatitis is much less common, with 86,000 people in the U.S
D., Bernier, M., Lpez-Lluch, G
What happens if treatment stops
Exercising on Ozempic: Essential Considerations for Optimal Results Ozempic (semaglutide) is a medication increasingly used for weight loss and diabetes management